Hiroko Sagara
Japan International Cooperation Agency
36 Papers
205 Citations
Hiroko Sagara is an academic researcher from Japan International Cooperation Agency. The author has contributed to research in topics: Paratyphoid fever & Typhoid fever. The author has an hindex of 10, co-authored 36 publications.
Chat about Author
Papers
Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates.
TL;DR: Examination of the kanamycin and chloramphenicol resistance genes of pNR9589 into Escherichia coli showed that the two genes are closely linked or clustered, and Restriction digests revealed that 50-kb plasmids from tetracycline-resistant C. jejuni isolates contain a common fragment related to Kanamycin resistance.
66
Fluoroquinolone-resistant Salmonella Paratyphi A.
TL;DR: An 87-year-old woman was referred from a local clinic to Yokohama Municipal Citizen's Hospital in July 2002 because Salmonella enterica serovar Paratyphi A was detected in her urine, and did not display any abnormal findings on physical examination.
32
A case of Penicillium marneffei infection in an AIDS patient: the first case in Japan.
TL;DR: A 38-year-old Japanese AIDS patient developed papular lesions which rapidly increased in number, eroded and crusted, and spread over not only skin but also the mucosal surface, and he died despite 2 months of intensive treatment.
Quantitation of HIV-1 group M proviral DNA using TaqMan MGB real-time PCR.
Makiko Kondo,Koji Sudo,Rie Tanaka,Takako Sano,Hiroko Sagara,Shinya Iwamuro,Yutaka Takebe,Mitsunobu Imai,Shingo Kato +8 more
TL;DR: The present real-time PCR assay is highly sensitive, linear, reproducible, accurate, and independent of group M subtypes, and useful for studying the relationship between HIV-1 proviral loads and the long-term efficacy of antiretroviral therapy for subtype B as well as non-B subtype strains.
20
Diagnosis of febrile illnesses in returned travelers using the PC software GIDEON.
TL;DR: GIDEON is a novel and potentially powerful tool in infectious disease diagnosis but improvements are required at the level of the developer and users are required to have adequate knowledge of infectious diseases for best use of the program.
17